BRPI0907512A2 - Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa natural - Google Patents

Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa natural

Info

Publication number
BRPI0907512A2
BRPI0907512A2 BRPI0907512-7A BRPI0907512A BRPI0907512A2 BR PI0907512 A2 BRPI0907512 A2 BR PI0907512A2 BR PI0907512 A BRPI0907512 A BR PI0907512A BR PI0907512 A2 BRPI0907512 A2 BR PI0907512A2
Authority
BR
Brazil
Prior art keywords
interferon alpha
host defense
defense mechanism
natural interferon
genetic regulation
Prior art date
Application number
BRPI0907512-7A
Other languages
English (en)
Inventor
William A Carter
David Strayer
Original Assignee
Hemispherx Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemispherx Biopharma Inc filed Critical Hemispherx Biopharma Inc
Publication of BRPI0907512A2 publication Critical patent/BRPI0907512A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
BRPI0907512-7A 2008-02-15 2009-02-17 Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa natural BRPI0907512A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2930808P 2008-02-15 2008-02-15
US5136608P 2008-05-08 2008-05-08
PCT/US2009/000960 WO2009102497A2 (en) 2008-02-15 2009-02-17 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species

Publications (1)

Publication Number Publication Date
BRPI0907512A2 true BRPI0907512A2 (pt) 2015-07-21

Family

ID=40957441

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907512-7A BRPI0907512A2 (pt) 2008-02-15 2009-02-17 Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa natural

Country Status (11)

Country Link
US (1) US20110044946A1 (pt)
EP (1) EP2252323A4 (pt)
JP (1) JP2011512353A (pt)
KR (1) KR20110002836A (pt)
CN (1) CN101990438A (pt)
AU (1) AU2009215129B2 (pt)
BR (1) BRPI0907512A2 (pt)
CA (1) CA2715294A1 (pt)
NZ (1) NZ587372A (pt)
WO (1) WO2009102497A2 (pt)
ZA (1) ZA201005827B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2539418C1 (ru) * 2013-10-18 2015-01-20 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" Способ лечения местно-распространенного рака орофарингеальной зоны
CN116531491A (zh) * 2023-07-07 2023-08-04 北京三元基因药业股份有限公司 一种干扰素α1b在制备防治甲型流感病毒感染引发的疾病的药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049378A (en) * 1989-04-24 1991-09-17 Ciba-Geigy Canada Ltd. Prevention and treatment of porcine haemophilus pneumonia (PHP)
BR9709068A (pt) * 1996-05-09 2000-01-11 Pharma Pacific Pty Ltd Processo de tratamento.
US7041301B1 (en) * 1997-11-07 2006-05-09 Mayo Foundation For Medical Education And Research Interferon immunotherapy
US20040258663A1 (en) * 2003-05-08 2004-12-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon alpha
CA2644670A1 (en) * 2006-03-08 2008-05-08 Hemispherx Biopharma Inc. Broad spectrum immune and antiviral gene modulation by oral interferon

Also Published As

Publication number Publication date
EP2252323A4 (en) 2012-01-11
AU2009215129B2 (en) 2013-07-18
AU2009215129A1 (en) 2009-08-20
KR20110002836A (ko) 2011-01-10
WO2009102497A3 (en) 2009-11-05
US20110044946A1 (en) 2011-02-24
JP2011512353A (ja) 2011-04-21
ZA201005827B (en) 2011-10-26
WO2009102497A2 (en) 2009-08-20
EP2252323A2 (en) 2010-11-24
NZ587372A (en) 2012-11-30
CN101990438A (zh) 2011-03-23
CA2715294A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
NL301211I1 (nl) Olipudase alfa
BRPI1013227A2 (pt) pró-fármacos transportadores de interferon alfa
BRPI0912023A2 (pt) tipo de lâmpada led de turbo reto
BRPI0915741A2 (pt) bomba alternativa operada por flutuador
DK2125010T3 (da) Behandling af immunsygdom ved mukosal afgivelse af antigener ved anvendelse af genetisk modificeret lactobacillus
PT2455477E (pt) Plantas resistentes a doenças
BRPI0908968A2 (pt) Composição enriquecidas com hemicelulase para potencializar a hidrólise de biomassa
DK1996292T3 (da) Anvendelse af peptider til bekæmpelse af stråleskade
EP2389444A4 (en) PROCESSING BIOMASS
EP2474663A4 (en) ABRASIONAL ART LEATHER
EP2257327A4 (en) FACIAL MASK WITH UNIVERSAL FIT
EP2114534A4 (en) TRANSPARENT ANTIMICROBIAL FACIAL MASK
BRPI0914326A2 (pt) método para formar uma corrente de oxigênio quente
EP2471873A4 (en) ENERGY RAYS HARDENABLE ELASTOMER COMPOSITION
EP2442650A4 (en) SUBLINGUAL APOMORPHIN
EP2495286A4 (en) HARDENING COMPOSITION
BR112013009802A2 (pt) fotoiniciadores polimerizáveis para composições curáveis por leds
PL2074865T3 (pl) Sposób kontrolowania barwy światła wyjściowego lampy
EP2342298A4 (en) TRANSPARENT INORGANIC ORGANIC HYBRID MATERIALS OBTAINED BY PROCESSING AN AQUEOUS SOL GEL
FI20080018A0 (fi) Hissijärjestelmän liikkeenohjaus
FI20095567A0 (fi) Valonlähteen valmistaminen
DK2117564T3 (da) Anvendelse af chitosaner til forøgelse af neglevæksthastigheden
BR112012002975A2 (pt) composição para o controle de pragas
DK3603384T3 (da) Plante der er restistent over for bremia
BRPI1010295A2 (pt) aprimoramentos em uma máscara laríngea.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.